Atlas Trials

A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers

Clinical trial NCT03698695 · COMPLETED

Trial details

NCT number
NCT03698695
Sponsor
Theranexus
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cognitive ImpairmentAlzheimer Disease
Start date
2018-09-27
Primary completion
2019-10-20
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.